Pesquisa

Edição
Título
Autores
Lorlatinib in the treatment of ALK-positive non-small cell lung cancer
Gordeeva O., Meshcheryakova N., Meshcheryakov A.
Ceritinib in the treatment of ALK-positive non-small cell lung cancer
Gordeeva O., Ivanova K., Meshcheryakov A.
Clinical experience with the use of combination drug therapy in the first line treatment of metastatic non-small cell lung cancer
Ivanova F., Nikolaeva T., Spiridonova N., Afanasyeva L., Nikiforov P., Zharnikova T.
Rol' gistologicheskogo i molekulyarnogo analiza v vybore metoda lecheniya nemelkokletochnogo raka legkogo pozdnikh stadiy
Vladimirova L., Kit O., Sholokhova E.
TREATMENT OF NON-SMALL CELL LUNG CANCER: THE NEXT STEP
Borisova E., Gutorov S., Abramov M.
Complex treatment of lung cancer patients with brain metastases
Zaitsev A., Datsenko P., Ryabov A., Pikin O., Alekseeva G., Kisarev S., Kobyletskaya T., Kirsanova O.
Non-small lung cancer. Expanding therapeutic opportunities: pembrolizumab in a number of malignant tumors
Gutorov S., Borisova E., Abramov M., Lud A., Arutyunyan E.
Perspektivy primeneniya kapsul vinorelbina v sovremennoy onkologii
Gutorov S., Stepanchenko M., Lichinitser M.
Evaluation of immune response checkpoint dynamics in patients with lung cancer receiving immune therapy
Mochalova A.
OPTIMIZATION OF TREATMENT TACTICS USING TARGETED THERAPY IN METASTATIC AND LOCALLY ADVANCED SMALL CELL LUNG CANCER
Smolin A., Kryukov E., Konev A., Nikolaeva S., Shamanskaya Y., Gorbacheva A., Matveev A.
Novye napravleniya v targetnoy terapii nemelkokletochnogo raka legkogo
Shikeeva A., Kekeeva T., Zavalishina L., Andreeva Y., Zaletaev D., Frank G.
MAINTENANCE THERAPY IN STAGES IIIB-IV NON-SMALL-CELL LUNG CANCER
Gutorov S., Borisova Y., Gutorov S., Borisova E.
Neoadjuvant immunotherapy for non-small cell lung cancer
Semenova A., Protsenko S., Teletaeva G., Latipova D., Novik A.
Pembrolizumab in the treatment of patients with non-small cell lung cancer and metastatic brain lesion: a clinical review
Vakhabova Y., Kolomeytseva A., Kalinin D., Kozak E., Fedenko A.
Own experience of use of EGFR tyrosine kinase inhibitors and bevacizumab in the treatment of patients with non-small cell lung cancer
Kolomeytseva A., Gagarin I., Reutova E., Mochal'nikova V., Mazurenko N., Gorbunova V.
PAKLITAKSEL I KARBOPLATIN V LEChENII RASPROSTRANENNOGO NEMELKOKLETOChNOGO RAKA LEGKOGO: PREDVARITEL'NYE REZUL'TATY OTKRYTOGO PROSPEKTIVNOGO KLINIChESKOGO ISSLEDOVANIYa
Gorbunova V., Marenich A., Reutova E., Sheveleva L., Karaseva N., Bogdanova N., Uskov D., Khasanov R., Mukhametshina G., Tuzikov S., Khorinko A., Ivanov R., Par V.
ALK-pozitivnyy nemelkokletochnyy rak legkogo i metody ego lecheniya: obzor literatury
Laktionov K., Reutova E., Sarantseva K.
ALK-POZITIVNYY NEMELKOKLETOChNYY RAK LEGKOGO: NOVYE PATsIENTY I NOVYE VOZMOZhNOSTI LEKARSTVENNOGO LEChENIYa
Breder V., Laktionov K.
COMBINED TREATMENT OF NON-SMALL-CELL LUNG CANCER WITH BRAIN METASTASES: POTENTIALS FOR TARGETED THERAPY
Smolin A., Konev A., Nikolaeva S., Sidorenko V., Shamanskaya Y., Khaliyarova D., Smolin A., Konev A., N Nikolayev S., Sidorenko V., Shamanskaya Y., Khaliyarova D.
Hope or error: can combinations of EGFR tyrosine kinase inhibitors and other drugs replace monotherapy?
Moiseenko F.
Pharmacoeconomic analysis of pembrolizumab in combination with chemotherapy as the first line of advances non-squamous nonsmall cell lung cancer treatment
Zyryanov S., Frolov M., Zhuravleva M., Rogov V., Sakaeva D.
COMBINATION CHEMOTHERAPY OF ADVANCED NON-SMALL-CELL LUNG CANCER BY DRUGS PACLITAXEL AND CARBOPLATIN: AN OPEN PROSPECTIVE CLINICAL TRIAL
Gorbunova V., Marenich A., Reutova E., Sheveleva L., Karaseva N., Bogdanova N., Uskov D., Khasanov R., Mukhametshina G., Tuzikov S., Khorinko A., Prokopenko T., Sakayeva D., Borisov V., Gurov S., Ivanov R., Salafet O., Marenich A., Reutova E., Sheveleva L., Karaseva N., Bogdanova N., Uskov D., Mukhametshina G., Tuzikov S., Khorinko A., Prokopenko T., Sakaeva D., Borisov V., Gurov S., Ivanov R., Salafet O.
Non-small cell lung cancer complicated by bleeding: a clinical case
Budurova M., Kanzapetov M., Davydov M., Gerasimov S., Khaylenko V.
New molecular subtypes of non-small cell lung cancer and the possibilities of their treatment
Moiseenko F., Kudryavtsev A., Myslik A., Volkov N.
Neoadyavant therapy of non-small cell lung cancer: are there any perspectives?
Ragulin Y.
Possibilities of metabiotic therapy in the correction of gastrointestinal symptoms and violations of intestinal microbiota in patients with lung cancer during chemotherapy
Serkova M., Avalueva E., Orlov S.
ROLE OF NEW ANTIANGIOGENIC DRUGS IN THE SECOND-LINE TREATMENT OF NON-SMALL-CELL LUNG CANCER
Semenova A., Protsenko S., Novik A., Latipova D., Teletayeva G., Semiglazova T.
Effectiveness of a shortened cycle of monoimmunotherapy in non-small cell lung cancer
Artemieva E., Moiseenko F., Volkov N., Egorenkov V., Abduloeva N., Bogdanov A., Zhabina A., Levchenko N., Moiseenko V.
1 - 28 de 28 resultados
Dicas:
  • Palavras-chave são sensíveis a maiúsculas
  • Preposições e conjunções ingleses são ignoradas
  • Busca é feita por todos os palavras-chave (agente AND experimentador) por omissão
  • Use OR para pesquisar um termo exato, ex.: educação OR formação
  • Use parênteses para criar frases complexas, ex.: arquivo de ((revistas OR conferências) NOT teses)
  • Para pesquisar uma frase precisa use aspas duplas, ex.: "investigações científicas"
  • Exclua uma palavra utilizando o sinal - (hífen) ou operador NOT; ex.: concurso-de beleza ou concurso NOT de beleza
  • Use * como caractere-coringa, ex.: científic* recuperará as palavras "científico", "científicos", etc.

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies